FDG-PET in the clinical management of Hodgkin lymphoma

This publication has 69 references indexed in Scilit:

• The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis
  Cancer Treatment Reviews, 2004
• Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography—clinical use, interpretation methods, diagnostic improvements
  Seminars in Nuclear Medicine, 2003
• [¹⁸F]5-Fluoro-2-Deoxyuridine-PET for Imaging of Malignant Tumors and for Measuring Tissue Proliferation
  Cancer Biotherapy & Radiopharmaceuticals, 2003
• Long-term risk of second malignancy after treatment of Hodgkin’s disease: the influence of treatment, age andfollow-up time
  Annals of Oncology, 2002
• Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests
  BMJ, 2001
• Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?
  European Journal Of Cancer, 2000
• Long-term complications of treatment and causes of mortality after Hodgkin's disease
  Seminars in Radiation Oncology, 1996
• Prognostic factors in Hodgkin's disease
  Seminars in Radiation Oncology, 1996
• Residual mediastinal mass after treatment of Hodgkin's disease: A decision analysis
  Medical Hypotheses, 1992
• Gallium scanning in the management of mediastinal Hodgkin's disease
  European Journal of Haematology, 1989